NCT06078215View on ClinicalTrials.gov

CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke

PHASE4RecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

March 31, 2025

Conditions
Acute Ischemic Stroke
Interventions
COMBINATION_PRODUCT

Cerebrolysin

Intravenous infusion of 30 ml Cerebrolysine in 500 ml of buffered crystalloid solution intravenously initiated within 12 hours from symptoms onset

Trial Locations (1)

60-355

RECRUITING

University Hospital, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER